Insulin mediators in man: Effects of glucose ingestion and insulin resistance

Diabetologia

Volumn 40, Issue 5, 1997, Pages 557-563

  Shashkin, P N ^a   Shashkina, E F ^a   Fernqvist Forbes, E ^a   Zhou, Y P ^a   Grill, V ^a   Katz, A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cyclic AMP dependent protein kinase; inositol phosphoglycans; non insulin dependent diabetes mellitus; pyruvate dehydrogenase

Indexed keywords

GLUCOSE; INOSITOL DERIVATIVE; INSULIN; PROTEIN KINASE; PYRUVATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; GLUCOSE; HUMANS; INOSITOL PHOSPHATES; INSULIN; INSULIN ANTAGONISTS; INSULIN RESISTANCE; KINETICS; MALE; MIDDLE AGED; MYOCARDIUM; OBESITY; POLYSACCHARIDES; PYRUVATE DEHYDROGENASE COMPLEX; REFERENCE VALUES; SWINE; TIME FACTORS;

EID: 0030903171     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050715     Document Type: Article

References (26)

1. Larner J, Galasko G, Cheng K, DePaoli-Roach AA, Huang L, Daggy P, Kellogg J (1979) Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 206: 1408-1410
2. Jarett L, Seals JR (1979) Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle. Science 206: 1407-1408
3. Saltiel A, Cuatrecasas P (1988) In search of a second messenger for insulin. Am J Physiol 255:C1-C11
4. Romero G, Larner J (1993) Insulin mediators and the mechanism of insulin action. Adv Pharmacol 24: 21-50
5. Huang LC, Larner J (1993) Inositol phosphoglycan mediators of insulin action. The special role of chiroinositol in insulin resistance. Adv Prot Phosphatases 7: 373-392
6. Larner J, Huang LC, Schwartz CFW et al. (1988) Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiroinositol. Biochem Biophys Res Comm 151: 1416-1426
7. Huang LC, Fonteles MC, Houston DB, Zhang C, Larner J (1993) Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132: 652-657
8. Kennington AS, Hill CR, Craig J et al. (1990) Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. New Engl J Med 323: 373-378
9. Asplin I, Galasko G, Larner J (1993) Chiro-inositol deficiency and insulin resistance: a comparison of the chiroinositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci USA 90: 5924-5928
10. Saltiel A, Siegel M, Jacobs S, Cuatrecasas P (1982) Putative mediators of insulin action: regulation of pyruvate dehydrogenase and adenylate cyclase activities. Proc Natl Acad Sci USA 79: 3513-3517
11. Suzuki S, Toyota T, Tamura S et al. (1987) ATP-Mn2 + stimulates the generation of a putative mediator of insulin action. J Biol Chem 262: 3199-3204
12. Kerbey AL, Radcliffe PM, Randle PJ, Sugden PH (1979) Regulation of kinase reactions in pig heart pyruvate dehydrogenase complex. Biochem J 181: 427-433
13. Newman JD, Armstrong JM, Bornstein J (1985) Assay of insulin mediator activity with soluble pyruvate dehydrogenase phosphatase.Endocrinology 116: 1912-1919
14. Arnqvist H, Olsson P-O, von Shenck H (1987) Free and total insulin determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. Clin Chem 33: 93-96
15. c by a new liquid chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32: 1867-1872
16. Galasko GTF, Bao Y, Broomfield SJ, Hooper NM, Turner AJ, Larner J (1995) Circulating factors and insulin resistance. I. A novel myoinositol 1,2-cyclic phosphate phosphoglycan insulin antagonist from human plasma is elevated in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80: 2419-2429
17. Galasko GTF, Abe S, Lilley K, Huang LC, Zhang C, Larner J (1996) Circulating factors and insulin resistance. II. The action of the novel myo-inositol 1,2-cyclic inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphatase. J Clin Endocrinol Metab 81: 1051-1057
18. Rutanen E-M, Stenman S, Blum W, Kärkkäinen T, Lehtovirta P, Stenman U-H (1993) Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 77: 199-204
19. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, Ho KKY (1995) Energy metabolism and substrate oxidation in acromegaly. J Clin Endocrinol Metab 80: 486-491
20. Sinha MK, Caro JF (1985) Presence of an activator of pyruvate dehydrogenase in human circulation: elevation following a glucose load and possible relation to an insulin mediator. Biochem Biophys Res Comm 129: 41-45
21. Farese RV, Standaert ML, Yamada K et al. (1994) Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiroinositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc Natl Acad Sci USA 91: 11040-11044
22. Sanchez-Gutierrez JC, Sanchez-Arias JA, Valle JC, Guadano A, Samper B, Mato JM, Feliu JE (1994) Insulin resistance in the genetically obese (fa/fa) rats: changes in the glycosyl-phosphatidylinositol signaling system. Endocrinology 134: 1485-1492
23. Ostlund RE, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR (1993) D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 90: 9988-9992
24. Larner J, Craig JW (1996) Urinary myo-inositol-to-chiroinositol ratios and insulin resistance. Diabetes Care 19: 76-78
25. Alvarez JF, Sanchez-Arias JA, Guadano A, Estevez F, Varela I, Feliu JE, Mato JM (1991) Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Biochem J 274: 369-374
26. Malchoff CD, Huang L, Gillespie N, Villar-Palasi C, Schwartz CFW, Cheng K, Hewlett EL, Larner J (1987) A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3 ,5-monophosphate-dependent protein kinase: partial purification from rat liver: site and kinetic mechanism of action. Endocrinology 120: 1327-1337